Foxi3^em3Akg

CRISPR/Cas9 technology generated a C to G change resulting in a phenylalanine to leucine substitution at amino acid 218 (p.F218L). This is equivalent to the human p.F234L pathogenic variant identified in a Pakistani family with Goldenhar syndrome (craniofacial microsomia). (J:336768)